AS
Insider selling
Adam Schayowitz sold $358K of ZYME stock
Adam Schayowitz, EVP, Head of R&D of Zymeworks Inc. (ZYME), sold 13,832 shares of ZYME stock worth $358K, per an SEC Form 4 filed Oct 9, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Oct 9, 2026.
ZYME has moved +10.9% since the trade date, from $25.79 to $28.61 (Oct 30, 2026 close).
- Traded
- Oct 9, 2026
- Disclosed
- Oct 9, 2026
- Filing delay
- 0 days
- Price since
- +10.9%
- Role
- EVP, Head of R&D
- Source
- SEC Form 4
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.